Literature DB >> 12193277

A panel of monoclonal antibodies against human polycomb group proteins.

Karien M Hamer1, Richard G A B Sewalt, Jan L den Blaauwen, Thijs Hendrix, David P E Satijn, Arie P Otte.   

Abstract

Polycomb-group (PcG) proteins are chromatin-associated proteins that heritably repress gene activity in many organisms, including man. Two distinct human PcG complexes have been identified. The HPC/HPH PcG complex I contains the HPC, HPH, RING1, and BMI1 proteins, the EED/EZH2 PcG complex II contains the EED, EZH2, and YY1 proteins. Previously we found that the relative expression levels of proteins of the human PcG complexes I and II are severely deregulated in human tumors. These findings signify an important role for antibodies against human PcG proteins as diagnostic tools. To be able to produce standardized anti-human PcG antibodies, we developed a panel of five mouse monoclonal antibodies (MAbs) against the human PcG proteins HPC2, BMI1, RING1A, EED, and EZH2. All MAbs can be used for Western blot analysis and immunofluorescence labeling of tissue culture cells. With the exception of the MAb against HPC2, all MAbs can also be used in immunoprecipitation experiments and immunohistochemistry of human tissues. The novel MAbs are therefore valuable tools for the cell biological, biochemical, and pathological analysis of human PcG proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193277     DOI: 10.1089/153685902760213859

Source DB:  PubMed          Journal:  Hybrid Hybridomics        ISSN: 1536-8599


  16 in total

1.  Control of developmental regulators by Polycomb in human embryonic stem cells.

Authors:  Tong Ihn Lee; Richard G Jenner; Laurie A Boyer; Matthew G Guenther; Stuart S Levine; Roshan M Kumar; Brett Chevalier; Sarah E Johnstone; Megan F Cole; Kyo-ichi Isono; Haruhiko Koseki; Takuya Fuchikami; Kuniya Abe; Heather L Murray; Jacob P Zucker; Bingbing Yuan; George W Bell; Elizabeth Herbolsheimer; Nancy M Hannett; Kaiming Sun; Duncan T Odom; Arie P Otte; Thomas L Volkert; David P Bartel; Douglas A Melton; David K Gifford; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

2.  Failure of extra-embryonic progenitor maintenance in the absence of dosage compensation.

Authors:  Joshua W Mugford; Della Yee; Terry Magnuson
Journal:  Development       Date:  2012-05-09       Impact factor: 6.868

3.  Cdyl, a new partner of the inactive X chromosome and potential reader of H3K27me3 and H3K9me2.

Authors:  M Escamilla-Del-Arenal; S T da Rocha; C G Spruijt; O Masui; O Renaud; Arne H Smits; R Margueron; M Vermeulen; E Heard
Journal:  Mol Cell Biol       Date:  2013-10-21       Impact factor: 4.272

4.  The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion.

Authors:  Leonie M Kamminga; Leonid V Bystrykh; Aletta de Boer; Sita Houwer; José Douma; Ellen Weersing; Bert Dontje; Gerald de Haan
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

5.  Mammalian polycomb-like Pcl2/Mtf2 is a novel regulatory component of PRC2 that can differentially modulate polycomb activity both at the Hox gene cluster and at Cdkn2a genes.

Authors:  Xiangzhi Li; Kyo-Ichi Isono; Daisuke Yamada; Takaho A Endo; Mitsuhiro Endoh; Jun Shinga; Yoko Mizutani-Koseki; Arie P Otte; Miguel Casanova; Hiroshi Kitamura; Takehiko Kamijo; Jafar Sharif; Osamu Ohara; Tetsuro Toyada; Bradley E Bernstein; Neil Brockdorff; Haruhiko Koseki
Journal:  Mol Cell Biol       Date:  2010-11-08       Impact factor: 4.272

6.  Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL.

Authors:  Joost C van Galen; Jettie J F Muris; Joost J Oudejans; Wim Vos; Cindy P E Giroth; Gert J Ossenkoppele; Arie P Otte; Frank M Raaphorst; Chris J L M Meijer
Journal:  J Clin Pathol       Date:  2006-07-12       Impact factor: 3.411

7.  In vivo HP1 targeting causes large-scale chromatin condensation and enhanced histone lysine methylation.

Authors:  Pernette J Verschure; Ineke van der Kraan; Wim de Leeuw; Johan van der Vlag; Anne E Carpenter; Andrew S Belmont; Roel van Driel
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

8.  Developmental regulation of Suz 12 localization.

Authors:  Cecile C de la Cruz; Jia Fang; Kathrin Plath; Kathleen A Worringer; Dmitri A Nusinow; Yi Zhang; Barbara Panning
Journal:  Chromosoma       Date:  2005-06-29       Impact factor: 4.316

9.  Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation.

Authors:  Nathan D Montgomery; Della Yee; Stephanie A Montgomery; Terry Magnuson
Journal:  J Mol Biol       Date:  2007-10-22       Impact factor: 5.469

10.  In aggressive variants of non-Hodgkin lymphomas, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2.

Authors:  Lamia Abd Al Kader; Takashi Oka; Katsuyoshi Takata; Xu Sun; Hiaki Sato; Ichiro Murakami; Tomohiro Toji; Akihiro Manabe; Hiroshi Kimura; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2013-08-16       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.